Literature DB >> 30551468

Scutellarein selectively targets multiple myeloma cells by increasing mitochondrial superoxide production and activating intrinsic apoptosis pathway.

Lin Shi1, Yi Wu2, Dian Liang Lv2, Lei Feng2.   

Abstract

OBJECTIVES: Scutellarein is a flavonoid monomer found in traditional Chinese medicine such as Scutellaria barbata. This study aimed to investigate the cytotoxic effect of scutellarein treatment on multiple myeloma (MM) cells.
METHODS: circulating B lymphocytes (CBL) isolated from healthy donors' peripheral blood served as control for MM.1R and IM-9 MM cells. CLB and MM cells were treated with various concentrations of scutellarein before their cell viability and apoptosis being evaluated. Nude mice burdened with MM xenograft tumor were intravenously injected with different concentrations of scutellarein, and their tumor burden change were monitored. Apoptosis of MM cells or CBL after scutellarein treatment was assayed by measuring caspase-3, -8 and -9 activities. FADD or APAF1 gene knockdown in MM cells was achieved by lentiviral transfection. Amount of Cytochrome C in cytosol or mitochondria as well as that of Bax and Bcl-2 protein were evaluated by Western blot. Mitochondria-induced apoptosis was assayed by measuring mitochondrial membrane potential change. Production of general reactive oxygen species and mitochondrial superoxide in MM or CBL was detected after scutellarein treatment, which was reduced by MitoTEMPO or apocynin treatment, respectively.
RESULTS: Scutellarein treatment showed potent cytotoxicity on MM cells but not on viable CBL, and intravenous injection of scutellarein significantly reduced MM xenograft tumor burden in nude mice. Scutellarein treatment in MM cells activated the mitochondrial-mediated intrinsic apoptosis pathway by increasing the production of mitochondrial superoxide, which was reduced to ROS by NADPH, but this effect was weakened in healthy CBL. Co-treatment with scutellarein synergized with bortezomib in inducing apoptosis in MM cells in vitro and in reducing tumor volume in MM xenografted nude mice.
CONCLUSIONS: Scutellarein induced mitochondrial-mediated intrinsic apoptosis selectively on malignant cells comparing to healthy cells.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Mitochondria; Multiple myeloma; NADPH; ROS; Scutellarein; Superoxide

Mesh:

Substances:

Year:  2018        PMID: 30551468     DOI: 10.1016/j.biopha.2018.09.024

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  In Vivo Cardiac-specific Expression of Adenylyl Cyclase 4 Gene Protects against Klotho Deficiency-induced Heart Failure.

Authors:  Kai Chen; Shirley Wang; Zhongjie Sun
Journal:  Transl Res       Date:  2022-01-31       Impact factor: 10.171

2.  Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin.

Authors:  Lin Zhang; Ruoqiu Fu; Dongyu Duan; Ziwei Li; Bin Li; Yue Ming; Li Li; Rui Ni; Jianhong Chen
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

3.  Bruceine D Identified as a Drug Candidate against Breast Cancer by a Novel Drug Selection Pipeline and Cell Viability Assay.

Authors:  Claudia Cipriani; Maria Pires Pacheco; Ali Kishk; Maryem Wachich; Daniel Abankwa; Elisabeth Schaffner-Reckinger; Thomas Sauter
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-31

Review 4.  Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions.

Authors:  Chao-Chao Yu; Yi Li; Zhao-Jun Cheng; Xi Wang; Wei Mao; Ying-Wen Zhang
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

Review 5.  Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death.

Authors:  Mélody Caillot; Hassan Dakik; Frédéric Mazurier; Brigitte Sola
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.